Some countries shorten COVID-19 booster timelines in face of Omicron surge
Submitted by mike kraft on
Submitted by mike kraft on
Submitted by mike kraft on
Submitted by mike kraft on
Submitted by mike kraft on
NOT SO TENDER AND MILD — The early indications suggest that the Omicron variant of the coronavirus typically causes disease that is “mild.” But even if that turns out to be true, “mild” doesn’t mean “no big deal.”
Submitted by mike kraft on
...
Submitted by mike kraft on
Submitted by mike kraft on
The first major real-world study of the omicron Covid-19 variant found that it appeared to cause less severe illness in South Africa, where it was first discovered last month, but that two doses of the Pfizer-BioNTech vaccine offer reduced protection against it.
Submitted by mike kraft on
Submitted by mike kraft on
Submitted by mike kraft on